Your browser doesn't support javascript.
loading
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
van den Heerik, Anne Sophie V M; Horeweg, Nanda; de Boer, Stephanie M; Bosse, Tjalling; Creutzberg, Carien L.
Affiliation
  • van den Heerik ASVM; Department of Radiation Oncology, Leiden University Medical Center Centrum, Leiden, Zuid-Holland, The Netherlands a.v.m.van_den_heerik@lumc.nl.
  • Horeweg N; Department of Radiation Oncology, Leiden University Medical Center Centrum, Leiden, Zuid-Holland, The Netherlands.
  • de Boer SM; Department of Radiation Oncology, Leiden University Medical Center Centrum, Leiden, Zuid-Holland, The Netherlands.
  • Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
  • Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center Centrum, Leiden, Zuid-Holland, The Netherlands.
Int J Gynecol Cancer ; 31(4): 594-604, 2021 04.
Article in En | MEDLINE | ID: mdl-33082238
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2021 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2021 Type: Article Affiliation country: Netherlands